Table 4.
Microbleeds absent | Microbleeds present | Beta (95% CI) | p | |
---|---|---|---|---|
n | 18 | 12 | – | – |
ACE total | 60.1 (15.3) | 65.3 (18.8) | 0.33 (− 0.03 to 0.68) | 0.07 |
Function z-score | 0.19 (1.10) | − 0.35 (0.76) | − 0.45 (− 0.78 to − 0.11) | 0.01 |
CAF | 7.6 (4.3) | 4.8 (4.2) | − 0.22 (− 0.60 to 0.16) | 0.24 |
MDS-UPDRS | 47.9 (17.5) | 33.8 (18.0) | − 0.40 (− 0.79 to − 0.02) | 0.04 |
Mean (SD) or percentage where specified. General linear model with age as a covariate
Significant findings in bold
ACE Addenbrooke’s Cognitive Examination, CAF Clinician Assessment of Fluctuation, MDS-UPDRS revised Unified Parkinson’s Disease Rating Scale motor sub-scale